Do I need both EUDAMED and Swissdamed registration?

Whether you need both EUDAMED and Swissdamed registration depends entirely on your target markets. If you’re only selling in the EU, EUDAMED registration alone is sufficient. If you’re targeting Switzerland exclusively, Swissdamed registration is required. However, companies planning to commercialize medical devices in both the European Union and Switzerland must complete registrations in both databases to maintain regulatory compliance and market access.

What Exactly Are EUDAMED and Swissdamed, and Why Do They Exist?

EUDAMED and Swissdamed are mandatory regulatory databases designed to track medical devices and their manufacturers within their respective jurisdictions. These systems serve critical functions in modern medical device regulation:

• EUDAMED serves the European Union – Operating under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), providing centralized oversight across all EU member states
• Swissdamed covers Switzerland independently – Fulfilling the same regulatory functions within Switzerland’s medical device framework, maintaining the country’s autonomous regulatory requirements
• Enhanced patient safety through traceability – Both systems enable comprehensive device tracking from manufacturing through end-of-life, improving incident response and recall management
• Streamlined market surveillance capabilities – Regulatory authorities can monitor device performance, identify safety patterns, and coordinate enforcement actions more effectively
• Centralized regulatory oversight – Competent authorities gain unified visibility into their markets, facilitating better resource allocation and risk-based monitoring

These database requirements represent a fundamental shift toward data-driven regulatory oversight in medical device markets. EUDAMED registration became mandatory on May 28, 2026, following extensive system testing and validation. The registration process requires manufacturers to complete actor registration first, obtaining a Single Registration Number before proceeding with device-specific UDI registrations. Both systems collect comprehensive device data including Basic UDI-DI information, risk classifications, storage conditions, and critical safety warnings, creating unprecedented transparency in medical device markets while enabling more responsive regulatory oversight.

Do You Need Both Registrations, or Can You Choose One Over the Other?

Your registration requirements are determined by market access needs rather than preference, creating specific compliance obligations based on your commercial strategy:

• EU-only market access – Companies selling exclusively within EU member states require only EUDAMED registration, simplifying compliance while accessing the broader European market
• Switzerland-only market focus – Manufacturers targeting Switzerland alone must complete Swissdamed registration to meet local regulatory requirements
• Dual market strategy – Companies pursuing both EU and Swiss markets face mandatory registration in both systems, with no alternatives for maintaining legal compliance
• Phased market entry approaches – Some manufacturers prioritize EU markets initially due to size, completing EUDAMED first before expanding Swiss operations, while others leverage Switzerland’s potentially faster approval timelines
• Device-specific complexity considerations – High-risk devices face more stringent requirements in both systems, influencing resource allocation and timeline planning for registration completion

Strategic partnerships with European Authorized Representatives or Swiss Authorized Representatives can significantly streamline dual registration processes. These regulatory partners often provide coordinated submission approaches, shared documentation strategies, and operational efficiencies that make managing both databases more practical from cost and resource perspectives. The decision ultimately requires balancing market opportunity, regulatory complexity, and available resources while ensuring complete compliance in all intended markets.

What Happens if You Register for One but Not the Other?

Incomplete registration strategies create immediate legal barriers and operational consequences that extend far beyond simple market access restrictions:

• Immediate compliance violations – Attempting to sell in markets without proper database registration violates fundamental regulatory requirements, creating legal liability regardless of device safety or quality
• Market access blockage – EU authorities cannot approve device placement without valid EUDAMED registration, while Swiss regulators require Swissdamed compliance, making commercialization impossible
• Regulatory penalties and sanctions – Competent authorities may impose financial penalties, suspend existing authorizations, or require costly remediation efforts to address compliance gaps
• Post-market surveillance complications – Incomplete registration creates barriers to vigilance reporting, Field Safety Corrective Actions, and coordinated safety communications across jurisdictions
• Supply chain partnership barriers – Distributors and importers require valid registrations to fulfill their regulatory obligations, making partial compliance an obstacle to commercial relationships
• Quality management system impacts – Medical device compliance gaps can trigger audit findings and affect broader regulatory standing across multiple markets and product lines

These consequences compound over time, as regulatory violations can impact future submissions, market expansion opportunities, and stakeholder confidence. The interconnected nature of modern medical device regulation means that compliance gaps in one jurisdiction often create cascading effects across global operations, making complete registration essential for sustainable market success.

How Do the Registration Processes and Requirements Actually Differ?

Despite sharing similar regulatory objectives, EUDAMED and Swissdamed maintain distinct operational requirements that demand separate compliance approaches:

• Two-stage EUDAMED process – Requires actor registration approval from competent authorities or notified bodies before UDI device registration can proceed, potentially creating bottlenecks during peak submission periods
• Independent Swiss validation framework – Swissdamed operates under Switzerland’s autonomous regulatory system with unique validation rules, controlled vocabularies, and data model specifications
• Different technical specifications – Each system maintains distinct EMDN coding expectations, formatting requirements, and cross-field dependencies, requiring separate data preparation processes
• Varying documentation requirements – Technical files, risk assessments, and supporting evidence follow different standards between systems, particularly for legacy device transitions
• Distinct maintenance obligations – Ongoing update frequencies, change-management processes, and lifecycle compliance requirements follow separate timelines and procedures
• Legacy device transition differences – Regulatory requirements for MDD, AIMDD, and IVDD products vary between databases, with unique rules and deadlines for each system

Successfully managing dual registration requires sophisticated understanding of both systems’ technical and procedural differences while maintaining data consistency across submissions. The complexity extends beyond initial registration to ongoing maintenance, where each database demands dedicated resources for compliance lifecycle management. Companies benefit significantly from regulatory expertise and technical solutions that can navigate both systems’ requirements simultaneously, minimizing administrative burden while ensuring accurate, compliant registrations that support long-term market access goals.

How MedEnvoy Global Helps with EUDAMED and Swissdamed Registration

Understanding your specific market requirements and registration obligations helps ensure compliant market entry while avoiding costly delays or compliance gaps. MedEnvoy Global simplifies the complex dual registration process through our comprehensive regulatory support services and proprietary GloRIAS platform:

• Streamlined dual database management – Our GloRIAS platform enables simultaneous EUDAMED and Swissdamed submissions, maintaining data consistency while meeting each system’s unique requirements
• Expert regulatory guidance – Our team provides strategic consultation on market entry timing, registration sequencing, and compliance optimization across both jurisdictions
• Automated compliance monitoring – Real-time tracking of regulatory deadlines, update requirements, and maintenance obligations ensures ongoing compliance throughout device lifecycles
• Technical documentation support – We assist with EMDN coding, UDI management, and system-specific formatting requirements to prevent submission delays

Ready to navigate EUDAMED and Swissdamed registration with confidence? Contact MedEnvoy Global today to learn how our regulatory expertise and advanced platform can streamline your compliance journey and accelerate your market access goals.

Related Articles

• How do I get my Medical Device Approved for Europe?
• What Is Vigilance Reporting for Medical Devices?
• What Responsibilities Does a Swiss Authorized Representative Have?
• How Are Medical Devices Regulated in Mexico?
• How Does Brexit Affect Swiss Medical Device Sales?